These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9935260

  • 21. Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults.
    Pullman J, Champlin J, Vrooman PS.
    Int J Clin Pract; 2003 Jun; 57(5):377-84. PubMed ID: 12846341
    [Abstract] [Full Text] [Related]

  • 22. Trovafloxacin: an overview.
    Garey KW, Amsden GW.
    Pharmacotherapy; 1999 Jan; 19(1):21-34. PubMed ID: 9917076
    [Abstract] [Full Text] [Related]

  • 23. Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease.
    Cirau-Vigneron N, Barrier J, Becue J, Chartier M, Giraud JR, Landes P, Leng J, Raudrant D, Reme JM.
    Pharmatherapeutica; 1989 Jan; 5(5):312-9. PubMed ID: 2664816
    [Abstract] [Full Text] [Related]

  • 24. Penetration of trovafloxacin into gynecologic tissues.
    Martens MG, Maccato M, Van Hook C, Vincent J.
    Am J Surg; 1998 Dec; 176(6A Suppl):18S-22S. PubMed ID: 9935252
    [Abstract] [Full Text] [Related]

  • 25. Trovafloxacin: a new fluoroquinolone.
    Alghasham AA, Nahata MC.
    Ann Pharmacother; 1999 Jan; 33(1):48-60. PubMed ID: 9972385
    [Abstract] [Full Text] [Related]

  • 26. The antibacterial efficacy of trovafloxacin against an experimental infection with Listeria monocytogenes in hydrocortisone-treated mice.
    van Ogtrop ML.
    J Antimicrob Chemother; 1999 Aug; 44(2):229-34. PubMed ID: 10473230
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
    Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, Sondheimer SJ, Hendrix SL, Amortegui A, Trucco G, Songer T, Lave JR, Hillier SL, Bass DC, Kelsey SF.
    Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prospective randomized clinical trial assessing the efficacy of a short course of intravenously administered amoxicillin plus clavulanic acid followed by oral antibiotic in patients with uncomplicated acute diverticulitis.
    Ribas Y, Bombardó J, Aguilar F, Jovell E, Alcantara-Moral M, Campillo F, Lleonart X, Serra-Aracil X.
    Int J Colorectal Dis; 2010 Nov; 25(11):1363-70. PubMed ID: 20526718
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections.
    Hemsell DL, Wendel GD, Gall SA, Newton ER, Gibbs RS, Knuppel RA, Lane TW, Sweet RL.
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):722-7. PubMed ID: 3281462
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.
    File TM, Schlemmer B, Garau J, Cupo M, Young C, 049 Clinical Study Group.
    J Antimicrob Chemother; 2001 Jul; 48(1):67-74. PubMed ID: 11474633
    [Abstract] [Full Text] [Related]

  • 33. Susceptibility of 497 clinical isolates of gram-negative anaerobes to trovafloxacin and eight other antibiotics.
    Rotimi VO, Mokaddas EM, Jamal WY, Khodakhast FB, Verghese TL, Sanyal SC.
    J Chemother; 1999 Oct; 11(5):349-56. PubMed ID: 10632380
    [Abstract] [Full Text] [Related]

  • 34. Comparison of ticarcillin plus clavulanic acid with cefoxitin in the treatment of female pelvic infection.
    Pastorek JG, Aldridge KE, Cunningham GL, Faro S, Graffeo S, McNeeley GS, Tan JS.
    Am J Med; 1985 Nov 29; 79(5B):161-3. PubMed ID: 4073084
    [Abstract] [Full Text] [Related]

  • 35. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
    Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J.
    J Antimicrob Chemother; 1997 Jun 29; 39 Suppl B():87-92. PubMed ID: 9222076
    [Abstract] [Full Text] [Related]

  • 36. [Impetigo].
    Mazereeuw-Hautier J.
    Ann Dermatol Venereol; 2006 Feb 29; 133(2):194-207. PubMed ID: 16508614
    [No Abstract] [Full Text] [Related]

  • 37. Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
    Piper KE, Rouse MS, Ronningen KL, Steckelberg JM, Wilson WR, Patel R.
    Antimicrob Agents Chemother; 2000 Sep 29; 44(9):2554-6. PubMed ID: 10952616
    [Abstract] [Full Text] [Related]

  • 38. [Ulcus vulvae acutum. Report of 5 cases].
    De Sanctis V, De Rosa E, Vergine G, Govoni MR, Sprocati M, Virgili A.
    Minerva Pediatr; 2001 Oct 29; 53(5):465. PubMed ID: 11668270
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study.
    Holloway WJ.
    Am J Med; 1985 Nov 29; 79(5B):168-71. PubMed ID: 4073086
    [Abstract] [Full Text] [Related]

  • 40. The efficacy of trovafloxacin versus ceftriaxone in the treatment of experimental brain abscess/cerebritis in the rat.
    Nathan BR, Scheld WM.
    Life Sci; 2003 Aug 22; 73(14):1773-82. PubMed ID: 12888116
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.